›› 2014, Vol. 35 ›› Issue (12): 1365-1365.
• 论文 • Previous Articles Next Articles
DU Hong;HAO Jie;LU Jingchao;YANG Xiuchun;CUI Wei;LIU Fan
Published:
Abstract: ABSTRACT:Objective To examine the mechanisms by which the peroxisome proliferator-activated receptors (PPARs )-mediated pathways contribute to the antiplatelet activity of simvastatin.Methods Blood samples were donated from healthy volunteers in order to prepare human platelet suspensions.The effects of simvastatin on collagen-induced platelet activation and the activity of PPARs were measured by impedance aggregometry,flow cytometric analysis, enzyme-linked immunosorbent assay,and spectrofluorimetry.Results Simvastatin induced PPARα and PPARγ activation in a dose-dependent manner in platelet suspensions (P < 0.05). Additionally,simvastatin inhibited collagen-induced platelet aggregation,expression of CD62 and PAC-1,and Ca2+ mobilization.These effects of simvastatin on platelet responses were strongly reduced by adding selective PPARγ antagonist (P <0.05),but not PPARα antagonist.Conclusion Simvastin inhibition of platelet activation induced by collagen is mediated by PPARγ-dependent processes.
Key words: platelet activation, peroxisome proliferator-activated receptors, simvastin
CLC Number:
R331.124
DU Hong;HAO Jie;LU Jingchao;YANG Xiuchun;CUI Wei;LIU Fan. DU Hong;HAO Jie;LU Jingchao;YANG Xiuchun;CUI Wei;LIU Fan[J]. , 2014, 35(12): 1365-1365.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.hebmu.edu.cn/EN/
https://xuebao.hebmu.edu.cn/EN/Y2014/V35/I12/1365